PURPOSE: To estimate the prevalence of metabolic syndrome and insulin resistance in a cohort of Division 1 collegiate football players. METHODS: Ninety football players were evaluated in a cross-sectional study to estimate the prevalence of metabolic syndrome, insulin resistance, and associated risk factors. Obesity was defined as a body fat >or=25% determined by BOD POD measurements. The National Cholesterol Education Program Adult Treatment Panel III criteria were used to estimate prevalence of metabolic syndrome. Quantitative insulin sensitivity check index calculations were performed to estimate prevalence of insulin resistance. Linear regression techniques were used to determine association between body fat percentage and other measured continuous parameters. Fisher exact test was used to determine association between nominal variables, and one-way ANOVA compared the three groups defined by position. RESULTS: Summary measures showed a small prevalence of abnormal individual measurements. There was an association between body fat percentage and most evaluated parameters (P < 0.05). The prevalence of obesity, insulin resistance, and metabolic syndrome was 21%, 21%, and 9%, respectively. Obesity is closely associated with metabolic syndrome (P < 0.0001) and insulin resistance (P < 0.0001) in this population. All subjects with metabolic syndrome were obese, and the odds for insulin resistance in the obese group are 10.6 times the odds for the nonobese group. Linemen (n = 29) had 19 of the 19 obese subjects, 13 of the 19 subjects with insulin resistance, and all subjects with metabolic syndrome. CONCLUSIONS: There is a strong association between obesity and both metabolic syndrome and insulin resistance in Division 1 collegiate football players. Linemen are at significant risk for metabolic syndrome and insulin resistance compared with other positions. This may be predictive of future health problems in Division 1 collegiate football players, especially linemen.
PURPOSE: To estimate the prevalence of metabolic syndrome and insulin resistance in a cohort of Division 1 collegiate football players. METHODS: Ninety football players were evaluated in a cross-sectional study to estimate the prevalence of metabolic syndrome, insulin resistance, and associated risk factors. Obesity was defined as a body fat >or=25% determined by BOD POD measurements. The National Cholesterol Education Program Adult Treatment Panel III criteria were used to estimate prevalence of metabolic syndrome. Quantitative insulin sensitivity check index calculations were performed to estimate prevalence of insulin resistance. Linear regression techniques were used to determine association between body fat percentage and other measured continuous parameters. Fisher exact test was used to determine association between nominal variables, and one-way ANOVA compared the three groups defined by position. RESULTS: Summary measures showed a small prevalence of abnormal individual measurements. There was an association between body fat percentage and most evaluated parameters (P < 0.05). The prevalence of obesity, insulin resistance, and metabolic syndrome was 21%, 21%, and 9%, respectively. Obesity is closely associated with metabolic syndrome (P < 0.0001) and insulin resistance (P < 0.0001) in this population. All subjects with metabolic syndrome were obese, and the odds for insulin resistance in the obese group are 10.6 times the odds for the nonobese group. Linemen (n = 29) had 19 of the 19 obese subjects, 13 of the 19 subjects with insulin resistance, and all subjects with metabolic syndrome. CONCLUSIONS: There is a strong association between obesity and both metabolic syndrome and insulin resistance in Division 1 collegiate football players. Linemen are at significant risk for metabolic syndrome and insulin resistance compared with other positions. This may be predictive of future health problems in Division 1 collegiate football players, especially linemen.
Authors: Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield Journal: Arch Intern Med Date: 2003-02-24
Authors: Ram Weiss; James Dziura; Tania S Burgert; William V Tamborlane; Sara E Taksali; Catherine W Yeckel; Karin Allen; Melinda Lopes; Mary Savoye; John Morrison; Robert S Sherwin; Sonia Caprio Journal: N Engl J Med Date: 2004-06-03 Impact factor: 91.245
Authors: Eric T Trexler; Abbie E Smith-Ryan; J Bryan Mann; Pat A Ivey; Katie R Hirsch; Meredith G Mock Journal: J Strength Cond Res Date: 2017-01 Impact factor: 3.775
Authors: Tyler A Bosch; Aaron F Carbuhn; Philip R Stanforth; Jonathan M Oliver; Kathryn A Keller; Donald R Dengel Journal: J Strength Cond Res Date: 2019-05 Impact factor: 3.775
Authors: Jonathan M Oliver; Brad S Lambert; Steven E Martin; John S Green; Stephen F Crouse Journal: J Athl Train Date: 2012 May-Jun Impact factor: 2.860
Authors: Jonathan M Oliver; Dustin P Joubert; Aaron Caldwell; Steve E Martin; Stephen F Crouse Journal: Lipids Health Dis Date: 2015-04-21 Impact factor: 3.876
Authors: Deborah L Feairheller; Kristin R Aichele; Joyann E Oakman; Michael P Neal; Christina M Cromwell; Jessica M Lenzo; Avery N Perez; Naomi L Bye; Erica L Santaniello; Jessica A Hill; Rachel C Evans; Karla A Thiele; Lauren N Chavis; Allyson K Getty; Tia R Wisdo; JoAnna M McClelland; Kathleen Sturgeon; Pam Chlad Journal: Int J Vasc Med Date: 2016-01-24